The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Campaigns & Insights
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / September / Endophthalmitis: A Case for Acting Early
Retina Research & Innovations News

Endophthalmitis: A Case for Acting Early

Trial suggests early vitrectomy could deliver faster and greater visual recovery for patients with acute endophthalmitis

9/3/2026 3 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Report
  • Quiz
  • Poll
  • Topic Commentary
5 Key Takeaways
  • 1

    Acute endophthalmitis affects approximately 1 in 1,000–2,000 patients post-intraocular procedures, leading to severe visual impairment or blindness.

  • 2

    A Phase 2 study showed that early vitrectomy within 48–96 hours improved visual outcomes compared to conventional antibiotic treatment.

  • 3

    Patients who underwent early vitrectomy had a median improvement of 40 letters in vision, significantly higher than the 13 letters gained by the antibiotic-first group.

  • 4

    The early vitrectomy group experienced fewer non-serious adverse events and retinal detachments compared to those managed with antibiotics.

  • 5

    The study's findings support further investigation in a larger Phase 3 trial to confirm the benefits of early surgical intervention in endophthalmitis.

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: